Suyash Prasad is VP at Audentes Therapeutics, Inc. (BOLD). They have made 10 open-market trades across 2 companies since 2017, most recently 2022-07-06.
CIK 0001679129
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TSHA | SELL · 10b5-1 | 2022-07-05 | 2022-07-07 | $3.70 | $48K | +10.8% | +12.3% | -51.7% |
| TSHA | SELL | 2022-06-29 | 2022-07-01 | $3.63 | $319K | +24.0% | +21.7% | -40.1% |
| TSHA | SELL | 2021-06-29 | 2021-07-01 | $22.62 | $3.6M | -2.9% | -15.0% | -9.3% |
| BOLD | SELL | 2019-05-13 | 2019-05-15 | $36.98 | $738K | -2.1% | -1.5% | -11.5% |
| BOLD | SELL | 2019-02-25 | 2019-02-27 | $30.06 | $301K | +14.0% | +29.1% | +24.7% |
| BOLD | SELL | 2018-10-01 | 2018-10-02 | $36.47 | $536K | -19.8% | -14.8% | -38.2% |
| BOLD | SELL | 2018-07-02 | 2018-07-05 | $38.41 | $768K | -2.0% | -4.4% | -11.9% |
| BOLD | SELL | 2017-12-01 | 2017-12-05 | $28.49 | $421K | +8.0% | +49.1% | +22.8% |
| BOLD | SELL | 2017-09-01 | 2017-09-01 | $21.44 | $172K | +10.3% | +26.6% | +31.2% |
| BOLD | SELL | 2017-03-29 | 2018-03-29 | $30.03 | $234K | +21.8% | +24.4% | +27.3% |
| BOLD | SELL | 2017-03-27 | 2018-03-28 | $30.00 | $66K | +19.2% | +29.7% | +38.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.